-+ 0.00%
-+ 0.00%
-+ 0.00%

ELI LILLY SPOKESPERSON: CAREFULLY EVALUATING FDA'S DRUG SAFETY COMMUNICATION FOR GLP-1 RA & WILL RESPOND TO FDA PROMPTLY

Reuters·11/09/2026 17:12:02